N-acetylcysteine to help people cut back on alcohol
Treatments studied
Part of Mental health clinical trials.
This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have alcohol use disorder diagnosed by DSM-5 (a specific set of criteria clinicians use)
- In the last month, you had at least 21 standard drinks per week or at least two heavy drinking days
- You want to cut down or stop drinking
- You can understand and speak English enough to consent and answer study questions
- You have stable housing
- You can give written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether blocking certain body signals (alpha receptors) with a study medicine can help people with alcohol use disorder cut down or stop drinking. You may be able to join if you meet alcohol-use criteria and can safely take the study drug.
This Phase 2 study tests a program designed to help people cut down or stop heavy alcohol use and daily smoking at the same time. It will check your alcohol level at the start and uses urine tests during a short induction phase to confirm recent alcohol and ongoing smoking.
This Phase 2 trial studies whether an LSD treatment approach, combined with study procedures, can help people with moderate-to-severe alcohol use disorder cut down or stop drinking. It may help reset patterns around cravings and drinking, but it also requires careful safety screening.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
This study tests whether a new medication called NTX-2001 can help people with alcohol use disorder drink less. Researchers will measure how the drug affects alcohol consumption and safety in adults aged 21–60.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
Hear when a new Alcohol Use Disorder (AUD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.